Literature DB >> 20614492

Vanishing bile duct syndrome in human immunodeficiency virus: nevirapine hepatotoxicity revisited.

Rajan Kochar1, Moises I Nevah, Frank J Lukens, Michael B Fallon, Victor I Machicao.   

Abstract

Vanishing bile duct syndrome (VBDS) refers to a group of disorders characterized by prolonged cholestasis as a result of destruction and disappearance of intrahepatic bile ducts. Multiple etiologies have been indentified including infections, neoplastic disorders, autoimmune conditions and drugs. The natural history of this condition is variable and may involve resolution of cholestasis or progression with irreversible damage. VBDS is extremely rare in human immunodeficiency virus (HIV)-infected patients and anti-retroviral therapy has never been implicated as a cause. We encountered a young pregnant female with HIV and VBDS secondary to anti-retroviral therapy. Here, we report her clinical course and outcome.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20614492      PMCID: PMC2900728          DOI: 10.3748/wjg.v16.i26.3335

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  16 in total

1.  Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis.

Authors:  Hiroto Kita; Shuji Matsumura; Xiao-Song He; Aftab A Ansari; Zhe-Xiong Lian; Judy Van de Water; Ross L Coppel; Marshall M Kaplan; M Eric Gershwin
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

2.  Small bile duct abnormalities in sarcoidosis.

Authors:  J R Murphy; M H Sjogren; J W Kikendall; D A Peura; Z Goodman
Journal:  J Clin Gastroenterol       Date:  1990-10       Impact factor: 3.062

Review 3.  Small-duct primary sclerosing cholangitis.

Authors:  J Ludwig
Journal:  Semin Liver Dis       Date:  1991-02       Impact factor: 6.115

4.  Chlorpromazine-induced cholestatic liver disease with ductopenia.

Authors:  A Chlumská; R Curík; L Boudová; P Mukensnabl; P Klvana
Journal:  Cesk Patol       Date:  2001-07

Review 5.  Intrahepatic cholestasis of pregnancy.

Authors:  Victoria Geenes; Catherine Williamson
Journal:  World J Gastroenterol       Date:  2009-05-07       Impact factor: 5.742

6.  Late onset hepatitis and prolonged deterioration in hepatic function associated with nevirapine therapy.

Authors:  S Clarke; P Harrington; C Condon; D Kelleher; O P Smith; F Mulcahy
Journal:  Int J STD AIDS       Date:  2000-05       Impact factor: 1.359

7.  Idiopathic adulthood ductopenia. A cause of chronic cholestatic liver disease and biliary cirrhosis.

Authors:  J Ludwig; R H Wiesner; N F LaRusso
Journal:  J Hepatol       Date:  1988-10       Impact factor: 25.083

8.  Sclerosing cholangitis and histiocytosis X.

Authors:  H H Thompson; H A Pitt; K J Lewin; W P Longmire
Journal:  Gut       Date:  1984-05       Impact factor: 23.059

Review 9.  Cholestasis in HIV-infected patients.

Authors:  Helen S Te
Journal:  Clin Liver Dis       Date:  2004-02       Impact factor: 6.126

10.  Chlorpromazine-induced vanishing bile duct syndrome leading to biliary cirrhosis.

Authors:  D Moradpour; J Altorfer; R Flury; P Greminger; C Meyenberger; R Jost; M Schmid
Journal:  Hepatology       Date:  1994-12       Impact factor: 17.425

View more
  3 in total

1.  Vanishing Bile Duct Syndrome in an Adult Patient: Case Report and Review of the Literature.

Authors:  Paolo Izzo; Gaetano Gallo; Massimo Codacci Pisanelli; Giuliano D'Onghia; Leonardo Macci; Raimondo Gabriele; Andrea Polistena; Luciano Izzo; Sara Izzo; Luigi Basso
Journal:  J Clin Med       Date:  2022-06-07       Impact factor: 4.964

2.  Vanishing bile duct syndrome in human immunodeficiency virus infected adults: a report of two cases.

Authors:  Ana Paula Oppenheimer; Christopher Koh; Mary McLaughlin; John C Williamson; Thomas D Norton; Jennifer Laudadio; Theo Heller; David E Kleiner; Kevin P High; Caryn G Morse
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

3.  Vanishing Bile Duct Syndrome Associated With Non-Hodgkin's Lymphoma and Hepatitis E Virus Infection.

Authors:  Mansoor Zafar; Mariya Farooq; William Butler-Manuel; Mohammad Fawad Khattak; Usman Iqbal Rana; Tila Muhammad; Ian Hawley; Mark Whitehead; Muhammad Toqeer
Journal:  Cureus       Date:  2022-01-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.